RMD vs. DXCM
Compare and contrast key facts about ResMed Inc. (RMD) and DexCom, Inc. (DXCM).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: RMD or DXCM.
Correlation
The correlation between RMD and DXCM is 0.52, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
RMD vs. DXCM - Performance Comparison
Loading data...
Key characteristics
RMD:
0.51
DXCM:
-0.58
RMD:
0.84
DXCM:
-0.40
RMD:
1.12
DXCM:
0.92
RMD:
0.43
DXCM:
-0.52
RMD:
1.93
DXCM:
-0.84
RMD:
8.23%
DXCM:
39.31%
RMD:
33.76%
DXCM:
58.70%
RMD:
-61.60%
DXCM:
-94.61%
RMD:
-11.96%
DXCM:
-46.59%
Fundamentals
RMD:
$36.90B
DXCM:
$33.52B
RMD:
$8.91
DXCM:
$1.33
RMD:
28.25
DXCM:
64.27
RMD:
1.50
DXCM:
1.32
RMD:
7.35
DXCM:
8.08
RMD:
6.65
DXCM:
14.79
RMD:
$5.02B
DXCM:
$4.15B
RMD:
$2.94B
DXCM:
$2.46B
RMD:
$1.71B
DXCM:
$889.80M
Returns By Period
The year-to-date returns for both investments are quite close, with RMD having a 11.27% return and DXCM slightly higher at 11.82%. Both investments have delivered pretty close results over the past 10 years, with RMD having a 17.52% annualized return and DXCM not far ahead at 17.61%.
RMD
11.27%
19.25%
6.29%
16.96%
9.62%
10.31%
17.52%
DXCM
11.82%
26.82%
14.02%
-33.80%
2.69%
-2.75%
17.61%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
RMD vs. DXCM — Risk-Adjusted Performance Rank
RMD
DXCM
RMD vs. DXCM - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for ResMed Inc. (RMD) and DexCom, Inc. (DXCM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
RMD vs. DXCM - Dividend Comparison
RMD's dividend yield for the trailing twelve months is around 0.84%, while DXCM has not paid dividends to shareholders.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
RMD ResMed Inc. | 0.84% | 0.88% | 1.07% | 0.83% | 0.62% | 0.73% | 0.98% | 1.26% | 1.61% | 2.03% | 2.16% | 1.89% |
DXCM DexCom, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
RMD vs. DXCM - Drawdown Comparison
The maximum RMD drawdown since its inception was -61.60%, smaller than the maximum DXCM drawdown of -94.61%. Use the drawdown chart below to compare losses from any high point for RMD and DXCM. For additional features, visit the drawdowns tool.
Loading data...
Volatility
RMD vs. DXCM - Volatility Comparison
The current volatility for ResMed Inc. (RMD) is 9.85%, while DexCom, Inc. (DXCM) has a volatility of 17.10%. This indicates that RMD experiences smaller price fluctuations and is considered to be less risky than DXCM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
RMD vs. DXCM - Financials Comparison
This section allows you to compare key financial metrics between ResMed Inc. and DexCom, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
RMD vs. DXCM - Profitability Comparison
RMD - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, ResMed Inc. reported a gross profit of 766.41M and revenue of 1.29B. Therefore, the gross margin over that period was 59.3%.
DXCM - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, DexCom, Inc. reported a gross profit of 589.00M and revenue of 1.04B. Therefore, the gross margin over that period was 56.9%.
RMD - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, ResMed Inc. reported an operating income of 426.27M and revenue of 1.29B, resulting in an operating margin of 33.0%.
DXCM - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, DexCom, Inc. reported an operating income of 133.70M and revenue of 1.04B, resulting in an operating margin of 12.9%.
RMD - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, ResMed Inc. reported a net income of 365.04M and revenue of 1.29B, resulting in a net margin of 28.3%.
DXCM - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, DexCom, Inc. reported a net income of 105.40M and revenue of 1.04B, resulting in a net margin of 10.2%.